X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES MERCK LTD ALKEM LABORATORIES/
MERCK LTD
 
P/E (TTM) x - 44.0 - View Chart
P/BV x 6.5 6.4 100.9% View Chart
Dividend Yield % 0.7 0.5 126.5%  

Financials

 ALKEM LABORATORIES   MERCK LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
MERCK LTD
Dec-17
ALKEM LABORATORIES/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,5891,358 117.1%   
Low Rs1,232933 132.0%   
Sales per share (Unadj.) Rs417.5665.0 62.8%  
Earnings per share (Unadj.) Rs56.356.6 99.5%  
Cash flow per share (Unadj.) Rs64.772.5 89.3%  
Dividends per share (Unadj.) Rs12.7015.00 84.7%  
Dividend yield (eoy) %0.91.3 68.7%  
Book value per share (Unadj.) Rs292.9441.7 66.3%  
Shares outstanding (eoy) m119.5716.60 720.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.7 196.2%   
Avg P/E ratio x25.120.2 123.8%  
P/CF ratio (eoy) x21.815.8 137.9%  
Price / Book Value ratio x4.82.6 185.7%  
Dividend payout %22.626.5 85.1%   
Avg Mkt Cap Rs m168,65319,011 887.1%   
No. of employees `000NA1.5 0.0%   
Total wages/salary Rs m9,1711,696 540.6%   
Avg. sales/employee Rs ThNM7,150.0-  
Avg. wages/employee Rs ThNM1,098.7-  
Avg. net profit/employee Rs ThNM608.2-  
INCOME DATA
Net Sales Rs m49,91511,040 452.1%  
Other income Rs m1,645240 686.3%   
Total revenues Rs m51,56111,279 457.1%   
Gross profit Rs m8,4821,376 616.4%  
Depreciation Rs m1,006264 381.0%   
Interest Rs m6710-   
Profit before tax Rs m8,4511,352 625.1%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0170 0.0%   
Tax Rs m1,606583 275.6%   
Profit after tax Rs m6,731939 716.8%  
Gross profit margin %17.012.5 136.3%  
Effective tax rate %19.043.1 44.1%   
Net profit margin %13.58.5 158.5%  
BALANCE SHEET DATA
Current assets Rs m27,0627,523 359.7%   
Current liabilities Rs m15,3242,253 680.3%   
Net working cap to sales %23.547.7 49.3%  
Current ratio x1.83.3 52.9%  
Inventory Days Days6752 127.5%  
Debtors Days Days4141 101.8%  
Net fixed assets Rs m12,6101,240 1,017.1%   
Share capital Rs m239166 144.0%   
"Free" reserves Rs m34,4907,167 481.3%   
Net worth Rs m35,0277,333 477.7%   
Long term debt Rs m1,2120-   
Total assets Rs m54,3879,912 548.7%  
Interest coverage x13.6NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.91.1 82.4%   
Return on assets %13.69.5 143.6%  
Return on equity %19.212.8 150.1%  
Return on capital %24.920.8 119.8%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,5631,015 646.9%   
Fx outflow Rs m3,0123,043 99.0%   
Net fx Rs m3,552-2,028 -175.1%   
CASH FLOW
From Operations Rs m7,259537 1,352.7%  
From Investments Rs m1,864-476 -391.4%  
From Financial Activity Rs m-9,273-220 4,218.7%  
Net Cashflow Rs m-150-160 94.0%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 33.1 18.2 181.9%  
FIIs % 0.0 1.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 29.1 -  
Shareholders   68,381 28,591 239.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   IPCA LABS  SANOFI INDIA  DR. DATSONS LABS  ORCHID PHARMA LTD  NOVARTIS  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 629 Points Higher; Realty and Auto Stocks Witness Buying(Closing)

Indian share markets continued their momentum throughout the day and ended the day on a strong note. Gains were largely seen in the realty sector, telecom sector and auto sector.

Related Views on News

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Dec 12, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - FULFORD INDIA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS